Despite the increasing global burden of neurological disorders, there is a lack of effective diagnostic and therapeutic biomarkers. Proteins are often dysregulated in disease and have a strong genetic component. Here, we carry out a protein quantitative trait locus analysis of 184 neurologically-relevant proteins, using whole genome sequencing data from two isolated population-based cohorts (N = 2893). In doing so, we elucidate the genetic landscape of the circulating proteome and its connection to neurological disorders. We detect 214 independently-associated variants for 107 proteins, the majority of which (76%) are cis-acting, including 114 variants that have not been previously identified. Using two-sample Mendelian randomisation, we id...
Genome-wide association studies (GWAS) with intermediate phenotypes, like changes in metabolite and ...
Circulating proteins can be used to diagnose and predict disease-related outcomes. A deep serum prot...
Technology for high-throughout scanning of the human genome and its encoded proteins have rapidly de...
Despite the increasing global burden of neurological disorders, there is a lack of effective diagnos...
Background: Neurodegenerative diseases are among the most prevalent and devastating neurological dis...
Alzheimer disease (AD) is the most common neurodegenerative disease, affecting 6.2 million people mo...
Neurodegenerative diseases are characterized by slow progressive loss of one or more functions of th...
Abstract Comprehensive expression quantitative trait loci (eQTL) studies have been instrumental for...
Although plasma proteins may serve as markers of neurological disease risk, the molecular mechanisms...
Studies of the genetic regulation of cerebrospinal fluid (CSF) proteins may reveal pathways for trea...
Neurodegenerative disorders such as Alzheimer’s disease, Huntington’s disease, Parkinson’s disease, ...
Very often the clinical features of rare neurodegenerative disorders overlap with those of other, mo...
Genome-wide association studies (GWAS) with intermediate phenotypes, like changes in metabolite and ...
Circulating proteins can be used to diagnose and predict disease-related outcomes. A deep serum prot...
Technology for high-throughout scanning of the human genome and its encoded proteins have rapidly de...
Despite the increasing global burden of neurological disorders, there is a lack of effective diagnos...
Background: Neurodegenerative diseases are among the most prevalent and devastating neurological dis...
Alzheimer disease (AD) is the most common neurodegenerative disease, affecting 6.2 million people mo...
Neurodegenerative diseases are characterized by slow progressive loss of one or more functions of th...
Abstract Comprehensive expression quantitative trait loci (eQTL) studies have been instrumental for...
Although plasma proteins may serve as markers of neurological disease risk, the molecular mechanisms...
Studies of the genetic regulation of cerebrospinal fluid (CSF) proteins may reveal pathways for trea...
Neurodegenerative disorders such as Alzheimer’s disease, Huntington’s disease, Parkinson’s disease, ...
Very often the clinical features of rare neurodegenerative disorders overlap with those of other, mo...
Genome-wide association studies (GWAS) with intermediate phenotypes, like changes in metabolite and ...
Circulating proteins can be used to diagnose and predict disease-related outcomes. A deep serum prot...
Technology for high-throughout scanning of the human genome and its encoded proteins have rapidly de...